Cover Image
Read Now

Lipid modification cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease : final version

This guideline updates for primary prevention, the NICE technology appraisal, Statins for the prevention of cardiovascular events' (TA94, 2007) and reviews and updates the recommendations made in the NICE guideline Lipid Modification (CG67, 2008) for primary and secondary prevention of cardiova...

Full description

Bibliographic Details
Corporate Authors: National Clinical Guideline Centre for Acute and Chronic Conditions (Great Britain), National Institute for Health and Care Excellence (Great Britain)
Format: eBook
Language:English
Published: London National Clinical Guideline Centre 2014, July 2014
Series:NICE clinical guideline
Subjects:
Lipids / Blood
Risk Assessment / Methods
Hydroxymethylglutaryl-coa Reductase Inhibitors / Therapeutic Use
Mass Screening / Methods
Cardiovascular Diseases / Prevention & Control
Cholesterol, Ldl / Drug Effects
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Table of Contents:
  • Includes bibliographical references

Similar Items